Jean-Louis Constanza is one of the founders, and Chief Clinical and Development Officer, of Wandercraft. In the last 5 years he worked with many medical teams to adapt Wandercraft’s exo, the first autonomous walk robotic exoskeleton, to the needs of Neuro and PMR institutions and their patients. He has a 30 years experience in digital and robotics industries and start-ups.
Autonomous Walk Exoskeleton: first learnings from clinical trials and expectations
The first autonomous walk exoskeleton has been tested since 2017 and is now being used for patient treatment in Europe. The seminar aim is to present and discuss preliminary learnings, on-going clinical studies and expected impact on treatment for stroke patients and patients with severe gait disorder.
EVEN MORE SEMINARS
Dr Terry Gorst University of Plymouth
‘To sense is to move’: the sensory aspects of movement in Parkinson’s disease and stroke
Prof Jenny Freeman University of Plymouth
Balance and falls in neurological conditions- what does the evidence tell us?
Mark Madams Kings College Hospital NHS Foundation Trust
Implementing Advanced Nurse Practitioner programme in Neurosciences
Nilofar Niazi TRAINM
Case Study in Use of Technologies and Innovations in NeuroRehabilitation
Maroun Farah Senso Medical Labs
BioPot platform: development of EEG, EMG and Bioimpedance patch and tattoo wearables